Plain-English translation of NCT02365246 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atopic Dermatitis research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing immunoadsorption, a procedure that filters your blood to remove certain immune cells that trigger severe atopic dermatitis. The study will see whether this treatment can improve your skin when other medications haven't worked well enough. Researchers will measure how much your skin improves and look at changes in your blood and skin samples.
Severe atopic dermatitis can be stubborn and doesn't always respond well to standard treatments like phototherapy or immune-suppressing medications. This trial exists to see if removing specific immune cells from your blood might offer relief for people whose skin condition is hard to control.
You likely qualify if…
You likely don't qualify if…
You would come to the hospital for the blood-filtering procedure (called immunoadsorption) on 4 consecutive days in week 1, then again for 3 consecutive days in week 5, and finally for 3 consecutive days in week 9. During each procedure, blood is drawn out, filtered through a special column that removes certain immune cells, and returned to your body. Throughout the trial, doctors will examine your skin, take blood samples, and possibly examine small skin samples to see if the treatment is helping.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Belgium